PSMA-VG-01

N/A

Report date: 2026/05/14 20:00:28

NME

Base Information

Drug NamePSMA-VG-01

Drug Alias Name177Lu-PSMA-VG01PSMA-VG-01

ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radioactive therapeutic agent +[4]

Mechanisms of ActionProstate-Specific Membrane Antigen modulators

TargetsProstate-Specific Membrane Antigen

Therapy Area/IndicationsProstatic Neoplasms, Castration-ResistantProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesVitsGen Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesVitsGen Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms, Castration-Resistant

Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A